Peter Salzmann - Apr 27, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Executive Officer, Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Peter Salzmann
Stock symbol: IMVT
Transactions as of: Apr 27, 2022
Transactions value $: -$7,656
Form type: 4
Date filed: 4/29/2022, 07:05 AM
Previous filing: Apr 14, 2022
Next filing: May 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	-$7.66K	-1.62K	-0.29%	$4.72^*	557K	Apr 27, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Content

On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.